APPLICATION
BLA761225
TYPE
BLA
ORIGINAL APPROVAL
2024-02-29
LATEST ACTION
2024-02-29
ROUTE
INTRAMUSCULAR
DOSAGE FORM
POWDER, FOR SOLUTION
MARKETING STATUS
Prescription
Products
LETYBOPrescription
LETIBOTULINUMTOXINA-WLBG 0.1ML(4UNITS) · POWDER, FOR SOLUTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.